Literature DB >> 2902268

Do CD4-positive cytotoxic T cells damage islet beta cells in type 1 diabetes?

P de Berardinis1, M Londei, R F James, S P Lake, P H Wise, M Feldmann.   

Abstract

The mechanism by which islet beta cells are destroyed in type 1 diabetes is still unknown. Because in diabetes the majority of T cells activated in vivo express CD4 and the islet beta cells selectively express the HLA class II antigens needed for recognition by CD4-positive T cells, the possibility that selective damage to islet beta cells may be caused by CD4-positive cytotoxic cells was investigated. Activated T cells were cloned from a newly diagnosed diabetic patient, and many CD4 cytotoxic clones were detected. The clone with the highest cytolytic capacity lysed HLA class II compatible islet cells which had been induced by interferon gamma and tumour necrosis factor to express class II antigens. The specificity of the lysis was demonstrated by use of histoincompatible islets, other histocompatible target cells, and blocking by anti-class-II monoclonal antibodies. The results show that a CD4-positive T cell clone can lyse HLA class II matched islet cells; this process may be important in the pathogenesis of type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2902268     DOI: 10.1016/s0140-6736(88)92785-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  13 in total

1.  Early T-cell defects in pre-type 1 diabetes.

Authors:  L al Sakkaf; P Pozzilli; P J Bingley; M W Lowdell; J M Thomas; E Bonifacio; E A Gale; G F Bottazzo
Journal:  Acta Diabetol       Date:  1992       Impact factor: 4.280

Review 2.  What future for therapeutic prevention of type 1 (insulin-dependent) diabetes mellitus?

Authors:  P Pozzilli; A Signore; D Andreani
Journal:  Diabetologia       Date:  1992-11       Impact factor: 10.122

3.  Islet-reactive T cells are a marker of preclinical insulin-dependent diabetes.

Authors:  L C Harrison; S X Chu; H J DeAizpurua; M Graham; M C Honeyman; P G Colman
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

4.  In search of TCR restriction in autoreactive T cell in human autoimmunity: why is it so elusive?

Authors:  C Navarrete; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1993-02       Impact factor: 4.330

Review 5.  The immunologic insult in type 1 diabetes.

Authors:  M C Honeyman; L C Harrison
Journal:  Springer Semin Immunopathol       Date:  1993

Review 6.  Autoimmunity and the pathogenesis of glomerulonephritis.

Authors:  D B Oliveira; D K Peters
Journal:  Pediatr Nephrol       Date:  1990-03       Impact factor: 3.714

7.  Elevated serum placental isoferritin in newly diagnosed type 1 (insulin-dependent) diabetes mellitus. A possible marker for identification of high risk subjects.

Authors:  S Assa; C Moroz
Journal:  Diabetologia       Date:  1990-09       Impact factor: 10.122

Review 8.  Pathophysiology of diabetes. A review of selected recent developments and their impact on treatment.

Authors:  H Shamoon
Journal:  Drugs       Date:  1992       Impact factor: 9.546

9.  Role of infiltrating T cells for impaired glucose metabolism in pancreatic islets isolated from non-obese diabetic mice.

Authors:  E Strandell; S Sandler; C Boitard; D L Eizirik
Journal:  Diabetologia       Date:  1992-10       Impact factor: 10.122

10.  Experimental allergic myositis in SJL/J mice immunized with rabbit myosin B fraction: immunohistochemical analysis and transfer.

Authors:  S Matsubara; T Shima; M Takamori
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.